IL-17 in rheumatoid arthritis: a new target for treatment or just another cytokine?
- 1 April 2004
- journal article
- editorial
- Published by Elsevier in Joint Bone Spine
- Vol. 71 (2) , 87-90
- https://doi.org/10.1016/j.jbspin.2003.06.001
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Evolving concepts of rheumatoid arthritisNature, 2003
- Interleukin-17 increases the effects of IL-1β on muscle cells: arguments for the role of T cells in the pathogenesis of myositisJournal of Neuroimmunology, 2003
- Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritisClinical and Experimental Immunology, 2002
- PATHWAYS BY WHICH INTERLEUKIN 17 INDUCES ARTICULAR CARTILAGE BREAKDOWN IN VITRO AND IN VIVOCytokine, 2001
- The combination of tumor necrosis factor ? blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo modelArthritis & Rheumatism, 2001
- POTENTIAL CONTRIBUTION OF IL-17- PRODUCING TH1CELLS TO DEFECTIVE REPAIR ACTIVITY IN JOINT INFLAMMATION: PARTIAL CORRECTION WITH Th2-PROMOTING CONDITIONSCytokine, 2001
- Protein Expression and Functional Difference of Membrane-Bound and Soluble Receptor Activator of NF-κB Ligand: Modulation of the Expression by Osteotropic Factors and CytokinesBiochemical and Biophysical Research Communications, 2000
- Interleukin-17: A New Bone Acting Cytokine In VitroJournal of Bone and Mineral Research, 1999
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999
- Interleukin-17-induced Gene Expression in Articular Chondrocytes Is Associated with Activation of Mitogen-activated Protein Kinases and NF-κBJournal of Biological Chemistry, 1998